84 related articles for article (PubMed ID: 8278307)
1. Polymorphonuclear leukocytes activation: in vitro modulation by 6-methoxy-2-naphthylacetic acid, the major active metabolite of nabumetone.
Allegrezza-Giulietti A; Serretti R; Peroni M; Cervini C
Pharmacol Res; 1993 Sep; 28(2):163-73. PubMed ID: 8278307
[TBL] [Abstract][Full Text] [Related]
2. Beta-thromboglobulin and polymorphonuclear leukocytes activation. (Effects on chemiluminescence, release of membrane bound calcium, NADPH-oxidase activity and membrane fluidity).
Allegrezza-Giulietti A; Serretti R; Beccerica E; Ferretti G; Cervini C
Biochem Int; 1991 May; 24(2):273-9. PubMed ID: 1834061
[TBL] [Abstract][Full Text] [Related]
3. Platelet release products modulate some aspects of polymorphonuclear leukocyte activation.
Allegrezza-Giulietti A; Serretti R; Beccerica E; Muti S; Ferretti G; Cervini C
J Cell Biochem; 1991 Nov; 47(3):242-50. PubMed ID: 1838744
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drug, nabumetone, prevents indometacin-induced gastric damage via inhibition of neutrophil functions.
Ishiwata Y; Okamoto M; Yokochi S; Hashimoto H; Nakamura T; Miyachi A; Naito Y; Yoshikawa T
J Pharm Pharmacol; 2003 Feb; 55(2):229-37. PubMed ID: 12635655
[TBL] [Abstract][Full Text] [Related]
5. Liver insufficiency as a factor modifying the pharmacokinetic characteristic of the preparation nabumetone.
Maleev A; Vlahov V; Gruev I; Dierdorf D; Kostova N; Bacracheva N
Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):425-9. PubMed ID: 3759278
[TBL] [Abstract][Full Text] [Related]
6. Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses.
Soma LR; Uboh CE; Rudy JA; Smith MS
Am J Vet Res; 1996 Apr; 57(4):517-21. PubMed ID: 8712517
[TBL] [Abstract][Full Text] [Related]
7. The NADPH oxidase of human polymorphonuclear leukocytes. Evidence for regulation by multiple signals.
McPhail LC; Clayton CC; Snyderman R
J Biol Chem; 1984 May; 259(9):5768-75. PubMed ID: 6425297
[TBL] [Abstract][Full Text] [Related]
8. [Determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by HPLC].
Qin Y; Zou Y; Liang M; Huang Y; Yu Q
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):452-4. PubMed ID: 11387968
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine effect on the luminol-dependent chemiluminescence pattern of reactive oxygen species generation by human polymorphonuclear leukocytes.
Stolarek R; Białasiewicz P; Nowak D
Pulm Pharmacol Ther; 2002; 15(4):385-92. PubMed ID: 12220944
[TBL] [Abstract][Full Text] [Related]
11. Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: identification of new nabumetone metabolites.
Nobilis M; Mikušek J; Szotáková B; Jirásko R; Holčapek M; Chamseddin C; Jira T; Kučera R; Kuneš J; Pour M
J Pharm Biomed Anal; 2013 Jun; 80():164-72. PubMed ID: 23584048
[TBL] [Abstract][Full Text] [Related]
12. The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism.
Melarange R; Spangler R; Hoult JR
Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):195-200. PubMed ID: 8931119
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of NADPH-oxidase activity in human polymorphonuclear neutrophils by lipophilic ascorbic acid derivatives.
Schmid E; Figala V; Ullrich V
Mol Pharmacol; 1994 May; 45(5):815-25. PubMed ID: 8190099
[TBL] [Abstract][Full Text] [Related]
14. A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acid.
Ogata K; Takamura N; Tokunaga J; Ikeda T; Setoguchi N; Tanda K; Yamasaki T; Nishio T; Kawai K
Eur J Drug Metab Pharmacokinet; 2016 Apr; 41(2):179-86. PubMed ID: 25537338
[TBL] [Abstract][Full Text] [Related]
15. Photosensitizing properties of 6-methoxy-2-naphthylacetic acid, the major metabolite of the phototoxic non-steroidal anti-inflammatory and analgesic drug nabumetone.
Canudas N; Zamora D; Villamizar JE; Fuentes J; Castelli C; Taddei A
Pharmazie; 2005 Aug; 60(8):604-8. PubMed ID: 16124404
[TBL] [Abstract][Full Text] [Related]
16. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
[TBL] [Abstract][Full Text] [Related]
17. Effects of extracellular lactate on production of reactive oxygen species by equine polymorphonuclear leukocytes in vitro.
Echigoya Y; Morita S; Itou T; Sakai T
Am J Vet Res; 2012 Aug; 73(8):1290-8. PubMed ID: 22849690
[TBL] [Abstract][Full Text] [Related]
18. Extractionless determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by high-performance liquid chromatography.
de Jager AD; Hundt HK; Hundt AF; Swart KJ; Knight M; Roberts J
J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):247-51. PubMed ID: 10821411
[TBL] [Abstract][Full Text] [Related]
19. Prevention of macrophage adhesion molecule-1 (Mac-1)-dependent neutrophil firm adhesion by taxifolin through impairment of protein kinase-dependent NADPH oxidase activation and antagonism of G protein-mediated calcium influx.
Wang YH; Wang WY; Liao JF; Chen CF; Hou YC; Liou KT; Chou YC; Tien JH; Shen YC
Biochem Pharmacol; 2004 Jun; 67(12):2251-62. PubMed ID: 15163556
[TBL] [Abstract][Full Text] [Related]
20. Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone: Baeyer-Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acid
Matsumoto K; Hasegawa T; Ohara K; Kamei T; Koyanagi J; Akimoto M
Xenobiotica; 2021 Feb; 51(2):155-166. PubMed ID: 33146575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
